Postprandial Glycemia After Eating a Pasta Dish Made With Resistant Starch.

NCT ID: NCT05988580

Last Updated: 2024-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-01

Study Completion Date

2023-11-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Resistant starch partially resists hydrolyzation by digestive enzymes in humans. Consequently, it is not absorbed in the small intestine and goes directly to the large intestine, where it is fermented by the intestinal microbiota, acting as a prebiotic and stimulating the growth of beneficial bacteria in the colon. In addition, the effect of resistant starch on postprandial glucose metabolism is studying. Thus, the present research on healthy subjects has been proposed.

The main objective is to assess the effect on postprandial glycemia of eating a pasta dish made with resistant starch versus its original version.

For this purpose, a randomized, double blind crossover study has been designed.

Target sample size is 18 subjects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The arms of the study are two:

* Experimental group (pasta dish made with resistant starch).
* Control group (original pasta dish).

Volunteers who wish to participate in the study will be interviewed by phone to verify that they meet the main inclusion criteria. Volunteers who meet the main inclusion criteria will be invited to an information and screening visit to resolve any doubts. Volunteers who agree to participate in the study will sign the informed consent and will be randomly assigned to one of the two arms of the study.

The two visits (clinical investigation days) of the study will take place with the volunteers in a fasting state of 4 hours and separated by at least 1 week washout period. The day before the visit, volunteers won't be able to drink alcohol, drink and eat excessively, and/or sleep few hours. Both visits will consist of eating a pasta dish in a maximum of 15 minutes. Blood samples will be taken before eating and during the 2.5 hours after (30, 60, 90, 120 and 150 minutes), in order to analyze the evolution of blood glucose and insulin levels.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postprandial Glycemia Resistant Starch

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Randomised, double blind crossover intervention
Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
The products (experimental and placebo), will be produced by an external producer, who will retain the codes. None of the researchers involved in the study development or analyses will know the association until the end of the study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Experimental group

Subjects will consume a pasta dish with 20-22% of resistant starch

Group Type EXPERIMENTAL

Pasta dish with resistant starch

Intervention Type OTHER

Pasta dish with 20-22% of resistant starch

Original version of pasta dish

Intervention Type OTHER

Original pasta dish, not reinforced with resistant starch

Control group

Subjects will consume the original version of pasta dish

Group Type PLACEBO_COMPARATOR

Pasta dish with resistant starch

Intervention Type OTHER

Pasta dish with 20-22% of resistant starch

Original version of pasta dish

Intervention Type OTHER

Original pasta dish, not reinforced with resistant starch

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pasta dish with resistant starch

Pasta dish with 20-22% of resistant starch

Intervention Type OTHER

Original version of pasta dish

Original pasta dish, not reinforced with resistant starch

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age: 18-65 years.
* Body mass index: 18.5-29.9 kg/m2
* Volunteers who like and feel good with the ingredients of the dish.
* Good physical and psychological state.
* Volunteers undergoing pharmacological treatment will be maintained if the dose is stable for at least 3 months before the start of the study, excluding treatments that alter gastrointestinal function or glucose metabolism.
* Subjects must be able to understand and be willing to sign the informed consent, and must comply with all the procedures and requirements of the study.
* No weight variations considered relevant (+/- 3kg) in the last 3 months.

Exclusion Criteria

* Subjects with relevant functional or structural abnormalities of the digestive system, such as malformations, angiodysplasias, active peptic ulcers, chronic inflammatory or malabsorption diseases, hiatal hernia, reflux, etc.
* Subjects who have undergone surgical interventions with permanent sequelae in the digestive system (for example, gastroduodenostomy).
* Subjects with a high alcohol intake, more than 14 units (women) and 20 units (men).
* Women who are breastfeeding or pregnant.
* Subjects with liver disease.
* Subjects with some type of cancer or undergoing treatment for it, or who have not had a period of at least 5 years since its eradication.
* Subjects with allergies to any component of the product under study or any other food that interferes and makes it difficult to monitor the study.
* Subjects who present some type of cognitive and/or psychic impairment.
* Subjects in whom poor collaboration is expected or who, in the opinion of the investigator, have difficulties in following the study procedures.
* Subjects who work the night shift.
* Subjects who follow some type of supplementation that interferes with the study.
* Subjects who are immersed in some treatment for weight loss.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Clinica Universidad de Navarra, Universidad de Navarra

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Fermín I Milagro Yoldi, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Navarra

Idoia Ibero-Baraibar, PhD

Role: STUDY_CHAIR

University of Navarra

Carlos J González-Navarro, PhD

Role: STUDY_CHAIR

University of Navarra

Miguel López-Yoldi, PhD

Role: STUDY_CHAIR

University of Navarra

Salomé Pérez Diez

Role: STUDY_CHAIR

University of Navarra

Blanca Martínez de Morentin

Role: STUDY_CHAIR

University of Navarra

José I Riezu-Boj, PhD

Role: STUDY_CHAIR

University of Navarra

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre for Nutrition Research

Pamplona, Navarre, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ALISSEC 2.0

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.